Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis

Objectives The benefits of metered‐dose inhalers with a spacer (MDI+S) have increasingly been recognized as an alternative method of albuterol administration for treating pediatric asthma exacerbations. The aim of this systematic review was to compare the response to albuterol delivered through nebu...

Full description

Autores:
Payares Salamanca, Laura
Contreras-Arrieta, Sandra
Florez, Victor
Barrios-Sanjuanelo, Alexander
Stand-Niño, Ivan
Rodríguez-Martínez, Carlos E.
Tipo de recurso:
https://purl.org/coar/resource_type/c_6501
Fecha de publicación:
2020
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/4464
Acceso en línea:
https://hdl.handle.net/20.500.12495/4464
https://doi.org/10.1002/ppul.25077
Palabra clave:
Acute asthma
Aerosol therapy
Children
Jet nebulizer
Metered-dose inhaler
Rights
License
Acceso abierto
id UNBOSQUE2_7b2a733162d52910fd675643e4d03a47
oai_identifier_str oai:repositorio.unbosque.edu.co:20.500.12495/4464
network_acronym_str UNBOSQUE2
network_name_str Repositorio U. El Bosque
repository_id_str
dc.title.spa.fl_str_mv Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis
dc.title.translated.spa.fl_str_mv Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis
title Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis
spellingShingle Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis
Acute asthma
Aerosol therapy
Children
Jet nebulizer
Metered-dose inhaler
title_short Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis
title_full Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis
title_fullStr Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis
title_full_unstemmed Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis
title_sort Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis
dc.creator.fl_str_mv Payares Salamanca, Laura
Contreras-Arrieta, Sandra
Florez, Victor
Barrios-Sanjuanelo, Alexander
Stand-Niño, Ivan
Rodríguez-Martínez, Carlos E.
dc.contributor.author.none.fl_str_mv Payares Salamanca, Laura
Contreras-Arrieta, Sandra
Florez, Victor
Barrios-Sanjuanelo, Alexander
Stand-Niño, Ivan
Rodríguez-Martínez, Carlos E.
dc.subject.keywords.spa.fl_str_mv Acute asthma
Aerosol therapy
Children
Jet nebulizer
Metered-dose inhaler
topic Acute asthma
Aerosol therapy
Children
Jet nebulizer
Metered-dose inhaler
description Objectives The benefits of metered‐dose inhalers with a spacer (MDI+S) have increasingly been recognized as an alternative method of albuterol administration for treating pediatric asthma exacerbations. The aim of this systematic review was to compare the response to albuterol delivered through nebulization (NEB) with albuterol delivered through MDI+S in pediatric patients with asthma exacerbations. Methods We conducted an electronic search in MEDLINE/PubMed, EMBASE, Ovid, and ClinicalTrials. To be included in the review, a study had to a randomized clinical trial comparing albuterol delivered via NEB versus MDI+S; and had to report the rate of hospital admission (primary outcome), or any of the following secondary outcomes: oxygen arterial saturation, heart rate (HR), respiratory rate (RR), the pulmonary index score (PIS), adverse effects, and need for additional treatment. Results Fifteen studies (n = 2057) met inclusion criteria. No significant differences were found between the two albuterol delivery methods in terms of hospital admission (relative risk, 0.89; 95% confidence interval [CI], 0.55–1.46; I2 = 32%; p = .65). There was a significant reduction in the PIS score (mean difference [MD], −0.63; 95% CI, −0.91 to −0.35; I2 = 0%; p < .00001), and a significantly smaller increase in HR (better; MD −6.47; 95% CI, −11.69 to −1.25; I2 = 0%; p = .02) when albuterol was delivered through MDI+S than when it was delivered through NEB. Conclusions This review, an update of a previously‐published meta‐analysis, showed a significant reduction in the PIS and a significantly smaller increase in HR when albuterol was delivered through MDI+S than when it was delivered through NEB.
publishDate 2020
dc.date.accessioned.none.fl_str_mv 2020-10-15T23:03:04Z
dc.date.available.none.fl_str_mv 2020-10-15T23:03:04Z
dc.date.issued.none.fl_str_mv 2020
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.local.none.fl_str_mv Artículo de revista
dc.type.coar.none.fl_str_mv https://purl.org/coar/resource_type/c_6501
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
format https://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 1099-0496
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12495/4464
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1002/ppul.25077
dc.identifier.instname.spa.fl_str_mv instname:Universidad El Bosque
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourl.none.fl_str_mv repourl:https://repositorio.unbosque.edu.co
identifier_str_mv 1099-0496
instname:Universidad El Bosque
reponame:Repositorio Institucional Universidad El Bosque
repourl:https://repositorio.unbosque.edu.co
url https://hdl.handle.net/20.500.12495/4464
https://doi.org/10.1002/ppul.25077
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartofseries.spa.fl_str_mv Pediatric Pulmonology, 1099-0496, 2020
dc.relation.uri.none.fl_str_mv https://onlinelibrary.wiley.com/doi/abs/10.1002/ppul.25077
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.local.spa.fl_str_mv Acceso abierto
dc.rights.accessrights.none.fl_str_mv https://purl.org/coar/access_right/c_abf2
Acceso abierto
dc.rights.creativecommons.none.fl_str_mv 2020-09-17
rights_invalid_str_mv Acceso abierto
https://purl.org/coar/access_right/c_abf2
2020-09-17
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Wiley-Blackwell
dc.publisher.journal.spa.fl_str_mv Pediatric Pulmonology
Pediatric Pulmonology
institution Universidad El Bosque
bitstream.url.fl_str_mv https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/f907f88e-b7d1-49b4-adc8-8cfa86bbe7ff/download
https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/5d980917-6348-4388-ac7b-0bb2ffba2cb9/download
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
7210a811635d1799e7c05fee5d259be7
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad El Bosque
repository.mail.fl_str_mv bibliotecas@biteca.com
_version_ 1849967214914961408
spelling Payares Salamanca, LauraContreras-Arrieta, SandraFlorez, VictorBarrios-Sanjuanelo, AlexanderStand-Niño, IvanRodríguez-Martínez, Carlos E.2020-10-15T23:03:04Z2020-10-15T23:03:04Z20201099-0496https://hdl.handle.net/20.500.12495/4464https://doi.org/10.1002/ppul.25077instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coapplication/pdfengWiley-BlackwellPediatric PulmonologyPediatric PulmonologyPediatric Pulmonology, 1099-0496, 2020https://onlinelibrary.wiley.com/doi/abs/10.1002/ppul.25077Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysisMetered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysisArtículo de revistahttps://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Acute asthmaAerosol therapyChildrenJet nebulizerMetered-dose inhalerObjectives The benefits of metered‐dose inhalers with a spacer (MDI+S) have increasingly been recognized as an alternative method of albuterol administration for treating pediatric asthma exacerbations. The aim of this systematic review was to compare the response to albuterol delivered through nebulization (NEB) with albuterol delivered through MDI+S in pediatric patients with asthma exacerbations. Methods We conducted an electronic search in MEDLINE/PubMed, EMBASE, Ovid, and ClinicalTrials. To be included in the review, a study had to a randomized clinical trial comparing albuterol delivered via NEB versus MDI+S; and had to report the rate of hospital admission (primary outcome), or any of the following secondary outcomes: oxygen arterial saturation, heart rate (HR), respiratory rate (RR), the pulmonary index score (PIS), adverse effects, and need for additional treatment. Results Fifteen studies (n = 2057) met inclusion criteria. No significant differences were found between the two albuterol delivery methods in terms of hospital admission (relative risk, 0.89; 95% confidence interval [CI], 0.55–1.46; I2 = 32%; p = .65). There was a significant reduction in the PIS score (mean difference [MD], −0.63; 95% CI, −0.91 to −0.35; I2 = 0%; p < .00001), and a significantly smaller increase in HR (better; MD −6.47; 95% CI, −11.69 to −1.25; I2 = 0%; p = .02) when albuterol was delivered through MDI+S than when it was delivered through NEB. Conclusions This review, an update of a previously‐published meta‐analysis, showed a significant reduction in the PIS and a significantly smaller increase in HR when albuterol was delivered through MDI+S than when it was delivered through NEB.Acceso abiertohttps://purl.org/coar/access_right/c_abf2Acceso abierto2020-09-17http://purl.org/coar/access_right/c_abf2LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/f907f88e-b7d1-49b4-adc8-8cfa86bbe7ff/download8a4605be74aa9ea9d79846c1fba20a33MD52falseAnonymousREADTHUMBNAILLaura Payares‐Salamanca MD Sandra Contreras‐Arrieta _2020.jpgLaura Payares‐Salamanca MD Sandra Contreras‐Arrieta _2020.jpgimage/jpeg5775https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/5d980917-6348-4388-ac7b-0bb2ffba2cb9/download7210a811635d1799e7c05fee5d259be7MD53falseAnonymousREAD20.500.12495/4464oai:pruebas-update-repositorio-unbosque.cloudbiteca.com:20.500.12495/44642022-05-06T23:05:46.006Zmetadata.onlyhttps://pruebas-update-repositorio-unbosque.cloudbiteca.comRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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